Transcriptome-based variant calling and aberrant mRNA discovery enhance diagnostic efficiency for neuromuscular diseases.
Sung Eun HongJana KneisslAnna ChoMan Jin KimSoojin ParkJeongeun LeeSijae WooSora KimJun-Soon KimSoo Yeon KimSungwon JungJinkuk KimJe-Young ShinJong-Hee ChaeMurim ChoiPublished in: Journal of medical genetics (2022)
The RNA-Seq-based diagnosis of NMDs achieves an increased diagnostic rate and provided pathogenic status information, which is not easily accessible through exome analysis.